CRISPR Therapeutics (CRSPN.MX) Q1 2026 Earnings

12FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-45.32
-36.89
-28.45
-20.02

Details

Expected EPS
-20.0185461894
Actual EPS
-23.583796500000002
Surprise EPS
-3.57
Surprise Percent
+17.81%

Description

CRISPR Therapeutics (CRSPN.MX) has reported earnings of -23.583796500000002 per share for Q1 2026.

0 Comments

Share your thoughts